We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oral formulation of ketamine effective for treatment‐resistant depression.
- Abstract
The article examines the efficacy and safety of oral extended-release R-107 ketamine tablets for treating depression resistant to traditional treatments. Topics discussed include the study's design involving a Phase 2 trial across multiple countries, the observed effectiveness of various doses of R-107 compared to placebo, and common adverse effects like headache and dizziness.
- Subjects
KETAMINE; PATIENT safety; HEADACHE; DIZZINESS; ORAL drug administration; TREATMENT effectiveness; ANXIETY; INTRAVENOUS therapy; DRUG efficacy; MENTAL depression; DRUG tolerance
- Publication
Brown University Psychopharmacology Update, 2024, Vol 35, Issue 10, p6
- ISSN
1068-5308
- Publication type
Article
- DOI
10.1002/pu.31215